Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20141110003Not yet recruiting
Trial of dexmedetomidine, sponsored by Rockefeller Foundation. Primary endpoints: Postoperative cognitive function and Oxidative stress markers. Planned start Nov 2014; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20141110003.